… the administration of an oral drug is particularly demanding Citation[23]. In neurodegenerative
diseases, current lead generation strategies utilize drug targets that are identified based …

… for the most relevant neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s
disease, Huntington’s disease, Multiple Sclerosis and Amyotrophic Lateral Sclerosis. …

… to the therapy of neurodegenerative diseases. NRF2 regulation … targets for the treatment of
neurodegenerative diseases, as … in terms of unexplored potential drug targets, and we hope …

… Neurodegenerative disease are frequently characterized by … targets for the treatment of
neurodegeneration due to their role … many models of neurodegenerative diseases by using either …

… target for neurodegenerative diseases, we advocate the view that chemopreventive agents
might be suitable candidates to serve as lead compounds for the development of a new class …

… feature of the neurodegenerative diseases is apoptosis … are involved in neurodegeneration.
Abnormal levels of these … the pathogenesis of neurodegenerative diseases. This review aims …

… new kinases as potential drug targets for neurodegenerative diseases will create opportunities
for … in other disease indications supports the idea that with the best targets identified small …

… genetic and proteomic data to prioritize drug targets for neurodegenerative diseases. … 22
proteins as targets for neurodegenerative diseases and provided preliminary evidence for drug …

… in a preclinical animal model of the disease. These compounds then … neurodegenerative
disease targets and mechanisms, whether or not they have all the properties required of a drug …

… This review attempts to recapitulate both current and novel drug targets in the principal
neurodegenerative diseases (AD, PD, ALS, and HD) using in silico approaches …